“Our discovery of RORB for these selectively vulnerable cells gives us the opportunity to study in detail exactly why they ...

When Jonel first noticed she was having trouble moving her hands, a diagnosis of Alzheimer’s disease never crossed her mind.

Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer's disease is the most ...

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

Two new drug treatments prove effective in forestalling the start of early onset Alzheimer's; Roskamp will eventually offer ...

The results from Erie’s 2024 Walk to Cure Alzheimer’s are in and the Erie community showed plenty of support for the cause ...

New research suggests that familial risk of Alzheimer's disease may be higher depending on which parent is affected.

A recent study has revealed that Alzheimer’s disease, a condition that causes memory loss and cognitive decline, is most ...

The Lancaster Walk to End Alzheimer's raised more than $137,600 to support the care, support and research programs of the ...

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

signature in Alzheimer's Disease (AD). They also investigated miRNAs that could predict the transition from mild cognitive ...

New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...